Leukemic transformation of myeloproliferative neoplasms (MPNs) is associated with dismal outcomes. The genetic complexity of leukemic transformation of MPNs is being deciphered and will likely result in targeted therapy approaches. Ongoing trials are investigating the efficacy of emerging treatments for this high-risk patient population. This review has outlined recent progress in the understanding and treatment of leukemia arising from MPNs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.beha.2021.101323 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!